Overview
Hemiplegic migraine (HM) is a rare and severe subtype of migraine with aura characterized by episodes of temporary motor weakness or paralysis (hemiplegia) affecting one side of the body, accompanied by other aura symptoms such as visual disturbances, sensory changes, and speech difficulties. These episodes are followed by a typically severe, throbbing headache. The condition primarily affects the nervous system, specifically involving cortical spreading depression — a wave of neuronal and glial depolarization that spreads across the cerebral cortex. Episodes can be frightening, as symptoms may mimic a stroke, and in some cases can be accompanied by confusion, fever, prolonged weakness, seizures, or even coma. Hemiplegic migraine is classified into two main forms: familial hemiplegic migraine (FHM) and sporadic hemiplegic migraine (SHM). FHM is inherited in an autosomal dominant pattern and is associated with mutations in several genes, including CACNA1A (FHM1), ATP1A2 (FHM2), SCN1A (FHM3), and PRRT2 (FHM4). These genes encode ion channels or transporters critical for normal neuronal signaling. FHM1 caused by CACNA1A mutations is the most well-characterized form and may be associated with progressive cerebellar ataxia in some families. SHM presents with identical clinical features but occurs in individuals without a family history, potentially due to de novo mutations or multifactorial causes. Age of onset is typically in childhood or adolescence, though it can vary. There is currently no cure for hemiplegic migraine. Treatment focuses on managing acute attacks and preventing future episodes. Acute treatment may include analgesics, anti-nausea medications, and in some cases intranasal ketamine. Triptans and ergotamines are generally avoided due to theoretical concerns about vasoconstriction, though this remains debated. Preventive therapies may include verapamil, flunarizine, lamotrigine, valproate, or acetazolamide, particularly in FHM1 with cerebellar features. Management should be individualized and guided by a neurologist experienced in headache disorders.
Clinical phenotype terms— hover any for plain English:
Variable
Can be inherited in different ways depending on the underlying gene
Childhood to adulthood
Can begin any time from childhood through adulthood
Treatments
No FDA-approved treatments are currently listed for Familial or sporadic hemiplegic migraine.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Familial or sporadic hemiplegic migraine at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Familial or sporadic hemiplegic migraine.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Financial Resources
1 resourcesNURTEC ODT
Pfizer
Migraine
Travel Grants
No travel grants are currently matched to Familial or sporadic hemiplegic migraine.
Community
No community posts yet. Be the first to share your experience with Familial or sporadic hemiplegic migraine.
Start the conversation →Latest news about Familial or sporadic hemiplegic migraine
No recent news articles for Familial or sporadic hemiplegic migraine.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Familial or sporadic hemiplegic migraine
What is Familial or sporadic hemiplegic migraine?
Hemiplegic migraine (HM) is a rare and severe subtype of migraine with aura characterized by episodes of temporary motor weakness or paralysis (hemiplegia) affecting one side of the body, accompanied by other aura symptoms such as visual disturbances, sensory changes, and speech difficulties. These episodes are followed by a typically severe, throbbing headache. The condition primarily affects the nervous system, specifically involving cortical spreading depression — a wave of neuronal and glial depolarization that spreads across the cerebral cortex. Episodes can be frightening, as symptoms ma
At what age does Familial or sporadic hemiplegic migraine typically begin?
Typical onset of Familial or sporadic hemiplegic migraine is childhood to adulthood. Age of onset can vary across affected individuals.
What treatment and support options exist for Familial or sporadic hemiplegic migraine?
1 patient support program are currently tracked on UniteRare for Familial or sporadic hemiplegic migraine. See the treatments and support programs sections for copay assistance, eligibility, and contact details.